GAITHERSBURG, Md., April 25, 2024 (GLOBE NEWSWIRE) — The Altimmune team would like to express our sorrow and extend our heartfelt condolences to Dr. Stephen Harrison’s family following his tragic and unexpected passing.
Dr. Harrison’s countless contributions to advancing needed treatments for metabolic liver disease will leave a profound and lasting legacy throughout our field, with his patients and the people engaged in understanding and treating liver disease. His brilliance and vision were only rivaled by his eloquence, charisma and steadfast commitment to improving the lives of people with liver disease. He was a tireless advocate for patients and a deeply respected advisor, investigator and friend to Altimmune.
We will miss him greatly as we adjust to this tremendous loss for the community. We honor his memory and are grateful for having known and worked with him.
Contact:
Rich Eisenstadt
Chief Financial Officer
Phone: 240-654-1450
reisenstadt@altimmune.com
Global cybersecurity provider deepens sustainability commitment, aiming to secure a better future for the environment.SEATTLE,…
Following the positive progress announced to the market on the Uprated Connection Agreement and the…
Fingerprint Cards AB (FPC) will host a telephone conference and webcast presentation of its first…
Orrön Energy AB (“Orrön Energy”) will publish its financial report for the first quarter 2025…
Q1 2025 FOR SIILI: Siili continued AI strategy implementation and actions for profitability improvements, revenue…
Image by Andrew Jovic DÜSSELDORF, Germany, April 22, 2025 (GLOBE NEWSWIRE) -- Independent art collector…
This website uses cookies.